Profound Medical Corp is making waves on the TSX with a significant uptick in its stock price.
Profound Medical Corp (PRN.TO) is experiencing a remarkable surge, with its stock rising by 14.84% in today’s trading session. This increase reflects positive investor sentiment towards the company’s ongoing innovations in medical technology, especially in robotic and incisionless surgery.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$377.18M
52W high
$12.40
52W low
$5.23
1W change
-0.57%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 141.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+141.1% Upside
Current Price
C$10.38
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
41.4%
Annualized
90-Day Vol
51.6%
Annualized
Trend (90d)
+20.3%
Annualized drift
90d Mean
C$11.16
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.63 | C$9.22 – C$12.27 |
| 60 trading days | C$10.89 | C$8.90 – C$13.33 |
| 90 trading days | C$11.16 | C$8.72 – C$14.29 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a market cap of approximately CA$377 million, Profound Medical's recent performance highlights its growth potential as it continues to innovate in the healthcare sector.
Stock Surges by 14.84%
Profound Medical's stock closed at CA$11.92, showing strong investor interest and confidence in its future prospects.
Bull case
The company’s advancements in autonomous robotics and focus on incisionless surgery could set it up for future growth. Healthcare providers are increasingly looking for innovative solutions, which positions Profound Medical well in this evolving market.
Bear case
Despite today’s gains, some recent trial results have raised concerns about the efficacy of its products. This uncertainty could affect investor confidence in the long run.
Advertisement
Market Performance Overview
Today, Profound Medical Corp's stock is rising significantly, reflecting a 14.84% increase. This surge is noteworthy, especially given the company's recent focus on advancing its TULSA-PRO® system and the TULSA Procedure™. Investors seem optimistic about the potential to reshape surgical practices.
Recent Developments
While there haven’t been any announcements directly triggering today’s price movement, ongoing discussions about the company’s innovative technologies, particularly in robotic surgery, likely contribute to the positive sentiment. Investors may also be looking forward to the upcoming Q2 financial results on August 6, 2026, which could shed more light on the company's performance.
Looking Ahead
As Profound Medical continues to innovate in the medical technology space, investors will be closely watching its upcoming developments and trial results. Today’s market reaction suggests a strong belief in the company’s long-term potential, but ongoing concerns about product efficacy remain a critical factor.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
